Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
300 participants
OBSERVATIONAL
2006-01-31
2010-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Anemia in the Elderly
NCT00640172
Ferritin as a Predictor for Anemia in Pregnancy
NCT03565198
Red Cell Mass and Plasma Volume Measurements in Elderly Men and Women With Anemia
NCT01011361
Low-dose Iron Supplementation and Markers of Iron Status Among Non-anemic, Iron-deficient Women
NCT02683369
Trial To Evaluate the Efficacy of Intravenous Iron in Older Adults With Unexplained Anemia
NCT01309659
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Participants in this study will be evaluated at the NIA-ASTRA unit at Harbor Hospital in Baltimore. Testing will consist of both diagnostic and research blood and urine testing along with history and physical exam. An optional bone marrow aspirate or aspirate and biopsy may be performed if the patient permits and it is indicated for either research or clinical diagnostic purposes. All study information supporting a specific diagnosis will be provided to the patient and, at their request, to their primary care physician if specific treatment is indicated.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Hemoglobin (Hgb) less than 13 in males and females
Exclusion Criteria
* Participation within the past six weeks in another research study which the Principal Investigator believes is incompatible with this study
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institute on Aging (NIA)
NIH
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
National Institute on Aging
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
William Ershler, MD
Role: PRINCIPAL_INVESTIGATOR
NIA/NIH
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
National Institute on Aging
Baltimore, Maryland, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Guralnik JM, Eisenstaedt RS, Ferrucci L, Klein HG, Woodman RC. Prevalence of anemia in persons 65 years and older in the United States: evidence for a high rate of unexplained anemia. Blood. 2004 Oct 15;104(8):2263-8. doi: 10.1182/blood-2004-05-1812. Epub 2004 Jul 6.
Artz AS, Fergusson D, Drinka PJ, Gerald M, Bidenbender R, Lechich A, Silverstone F, McCamish MA, Dai J, Keller E, Ershler WB. Mechanisms of unexplained anemia in the nursing home. J Am Geriatr Soc. 2004 Mar;52(3):423-7. doi: 10.1111/j.1532-5415.2004.52116.x.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
AG0062
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.